476 related articles for article (PubMed ID: 33949929)
1. Machine Learning in Discovery of New Antivirals and Optimization of Viral Infections Therapy.
Tarasova O; Poroikov V
Curr Med Chem; 2021; 28(38):7840-7861. PubMed ID: 33949929
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on antiviral drug development.
Wainberg MA
Antiviral Res; 2009 Jan; 81(1):1-5. PubMed ID: 18948140
[TBL] [Abstract][Full Text] [Related]
3. Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade.
Serafim MSM; Dos Santos Júnior VS; Gertrudes JC; Maltarollo VG; Honorio KM
Expert Opin Drug Discov; 2021 Sep; 16(9):961-975. PubMed ID: 33957833
[No Abstract] [Full Text] [Related]
4. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review.
Akram M; Tahir IM; Shah SMA; Mahmood Z; Altaf A; Ahmad K; Munir N; Daniyal M; Nasir S; Mehboob H
Phytother Res; 2018 May; 32(5):811-822. PubMed ID: 29356205
[TBL] [Abstract][Full Text] [Related]
5. Antiviral drugs for viruses other than human immunodeficiency virus.
Razonable RR
Mayo Clin Proc; 2011 Oct; 86(10):1009-26. PubMed ID: 21964179
[TBL] [Abstract][Full Text] [Related]
6. Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens.
Prasad M; Ranjan K; Brar B; Shah I; Lalmbe U; Manimegalai J; Vashisht B; Gaury M; Kumar P; Khurana SK; Prasad G; Rawat J; Yadav V; Kumar S; Rao R
Curr Drug Metab; 2017; 18(10):942-970. PubMed ID: 28952435
[TBL] [Abstract][Full Text] [Related]
7. Systematic approaches towards the development of host-directed antiviral therapeutics.
Prussia A; Thepchatri P; Snyder JP; Plemper RK
Int J Mol Sci; 2011; 12(6):4027-52. PubMed ID: 21747723
[TBL] [Abstract][Full Text] [Related]
8. Current status and future perspectives of computational studies on human-virus protein-protein interactions.
Lian X; Yang X; Yang S; Zhang Z
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33693490
[TBL] [Abstract][Full Text] [Related]
9. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.
Wei Y; Li W; Du T; Hong Z; Lin J
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592
[TBL] [Abstract][Full Text] [Related]
10. [Antiviral therapy: from influenza to Pfeiffer's disease].
Salzberger B
Internist (Berl); 2006 Dec; 47(12):1245-50. PubMed ID: 17009040
[TBL] [Abstract][Full Text] [Related]
11. Current progress in antiviral strategies.
Lou Z; Sun Y; Rao Z
Trends Pharmacol Sci; 2014 Feb; 35(2):86-102. PubMed ID: 24439476
[TBL] [Abstract][Full Text] [Related]
12. [Viruses and antiviral drug resistance].
Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
[No Abstract] [Full Text] [Related]
13. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Brooks MJ; Sasadeusz JJ; Tannock GA
Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antiviral resistance across acute and chronic viral infections.
Mason S; Devincenzo JP; Toovey S; Wu JZ; Whitley RJ
Antiviral Res; 2018 Oct; 158():103-112. PubMed ID: 30086337
[TBL] [Abstract][Full Text] [Related]
15. Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
McKimm-Breschkin JL; Fry AM
Antiviral Res; 2016 May; 129():21-38. PubMed ID: 26872862
[TBL] [Abstract][Full Text] [Related]
16. Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.
Matthew AN; Leidner F; Lockbaum GJ; Henes M; Zephyr J; Hou S; Rao DN; Timm J; Rusere LN; Ragland DA; Paulsen JL; Prachanronarong K; Soumana DI; Nalivaika EA; Kurt Yilmaz N; Ali A; Schiffer CA
Chem Rev; 2021 Mar; 121(6):3238-3270. PubMed ID: 33410674
[TBL] [Abstract][Full Text] [Related]
17. Covalent Antiviral Agents.
Mirzaie S; Abdi F; GhavamiNejad A; Lu B; Wu XY
Adv Exp Med Biol; 2021; 1322():285-312. PubMed ID: 34258745
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy.
Pizzorno A; Padey B; Terrier O; Rosa-Calatrava M
Front Immunol; 2019; 10():531. PubMed ID: 30941148
[TBL] [Abstract][Full Text] [Related]
19. Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules.
Mohan S; Elhassan Taha MM; Makeen HA; Alhazmi HA; Al Bratty M; Sultana S; Ahsan W; Najmi A; Khalid A
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105694
[TBL] [Abstract][Full Text] [Related]
20. [Antiviral activity of extracts of basidiomycetes and humic compounds substances against Human Immunodeficiency Virus (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus 1) and Herpes Simplex Virus (Herpesviridae: Simplexvirus: Human alphaherpesvirus 1)].
Nosik DN; Nosik NN; Teplyakova TV; Lobach OA; Kiseleva IA; Kondrashina NG; Bochkova MS; Ananko GG
Vopr Virusol; 2020 Nov; 65(5):276-283. PubMed ID: 33533211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
